Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fouts

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Expert Opinion on Biological Therapy|April 14, 2006
Antibody-based inhibitors of HIV infectionVidita Choudhry, Mei-Yun Zhang, Dimana Dimitrova, et al.
Vaccine|May 2, 2002
Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1Anthony L Devico, Timothy R Fouts, Mohamed T Shata, et al.
Experimental Lung Research|August 1, 1981
Identification of cytochrome P-450 isozymes in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lungT R Devereux, C J Serabjit-Singh, S R Slaughter, et al.
Chemico-Biological Interactions|August 1, 1983
Hepatic microsomal NADPH-cytochrome P-450 reductase from little skate, Raja erinacea. Comparison of thermolability and other molecular properties with a mammalian enzymeR J Pohl, C J Serabjit-Singh, S R Slaughter, et al.
Biochemistry|May 30, 2002
Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogensYen-Hung Chow, Olivia L Wei, Sanjay Phogat, et al.
Vaccine|June 14, 2003
Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxinK C Bagley, M T Shata, D Y Onyabe, et al.
FEMS Immunology and Medical Microbiology|July 2, 2003
Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1T R Fouts, A L DeVico, D Y Onyabe, et al.
Molecular Phylogenetics and Evolution|April 15, 2000
Proposal for a human genome evolution projectE H McConkey, R Fouts, M Goodman, et al.
Journal of Virology|March 14, 1998
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageD C Montefiori, R G Collman, T R Fouts, et al.
AIDS Research and Human Retroviruses|March 8, 2016
Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal LactobacillusAngela Marcobal, Xiaowen Liu, Wenlei Zhang, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Expert Opinion on Biological Therapy|April 14, 2006
Antibody-based inhibitors of HIV infectionVidita Choudhry, Mei-Yun Zhang, Dimana Dimitrova, et al.
Vaccine|May 2, 2002
Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1Anthony L Devico, Timothy R Fouts, Mohamed T Shata, et al.
Experimental Lung Research|August 1, 1981
Identification of cytochrome P-450 isozymes in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lungT R Devereux, C J Serabjit-Singh, S R Slaughter, et al.
Chemico-Biological Interactions|August 1, 1983
Hepatic microsomal NADPH-cytochrome P-450 reductase from little skate, Raja erinacea. Comparison of thermolability and other molecular properties with a mammalian enzymeR J Pohl, C J Serabjit-Singh, S R Slaughter, et al.
Biochemistry|May 30, 2002
Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogensYen-Hung Chow, Olivia L Wei, Sanjay Phogat, et al.
Vaccine|June 14, 2003
Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxinK C Bagley, M T Shata, D Y Onyabe, et al.
FEMS Immunology and Medical Microbiology|July 2, 2003
Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1T R Fouts, A L DeVico, D Y Onyabe, et al.
Molecular Phylogenetics and Evolution|April 15, 2000
Proposal for a human genome evolution projectE H McConkey, R Fouts, M Goodman, et al.
Journal of Virology|March 14, 1998
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageD C Montefiori, R G Collman, T R Fouts, et al.
AIDS Research and Human Retroviruses|March 8, 2016
Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal LactobacillusAngela Marcobal, Xiaowen Liu, Wenlei Zhang, et al.
Pageof 15